Evidence map›Paper›PMID 37700837›Full record

ArticleFrontiers in oncology2023

Wedge resection vs. segmentectomy for lung cancer measuring ≤ 2 cm with consolidation tumor ratio > 0.25.

Tetsuya Isaka, Takuya Nagashima, Hiroyuki Adachi, Hiroto Narimatsu, Kotaro Murakami, Shunsuke Shigefuku, Noritake Kikunishi, Naoko Shigeta, Kozue Watabe, Yujin Kudo and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Tetsuya IsakaDepartment of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Takuya NagashimaDepartment of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Hiroyuki AdachiDepartment of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Hiroto NarimatsuDepartment of Genetic Medicine, Kanagawa Cancer Center, Yokohama, Japan.
Kotaro MurakamiDepartment of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Shunsuke ShigefukuDepartment of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Noritake KikunishiDepartment of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Naoko ShigetaDepartment of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Kozue WatabeDepartment of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Yujin KudoDepartment of Surgery, Tokyo Medical University, Tokyo, Japan.
Yoshihiro MiyataDepartment of Surgical Oncology, Hiroshima University, Hiroshima, Japan.
Morihito OkadaDepartment of Surgical Oncology, Hiroshima University, Hiroshima, Japan.
Norihiko IkedaDepartment of Surgery, Tokyo Medical University, Tokyo, Japan.
Hiroyuki ItoDepartment of Thoracic Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Kanagawa Prefectural Hospital Organization · JPKanagawa Cancer CenterHiroshima University · JPTokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: We aimed to clarify the differences in prognosis between wedge resection and segmentectomy performed for cN0 non-small cell lung cancer (NSCLC) measuring ≤ 2 cm, with consolidation tumor ratio (CTR) > 0.25. Methods: This multicenter study included 570 patients with cN0 NSCLC (tumor size ≤ 2 cm, CTR > 0.25) who underwent wedge resection (n = 244) and segmentectomy (n = 326) between January 2010 and December 2018. After propensity score matching (PSM, 1:1 method), 182 patients were matched for clinical characteristics (age, sex, laterality, smoking index, tumor size, CTR, carcinoembryonic antigen value, positron-emission tomography-documented maximum standardized uptake value, clinical stage, and tumor disappearance rate) and intergroup comparison of disease-free survival (DFS) and overall survival (OS). Using Gray's test, an intergroup comparison of the cumulative incidence of lung cancer-specific mortality was performed. Results: After PSM, similar DFS (5-year DFS, 79.9% vs. 87.1%, p = 0.103) and OS (5-year OS, 88.7% vs. 88.9%, p = 0.719) rates were observed in the wedge resection and segmentectomy groups. We observed no significant intergroup differences in lung cancer-specific mortality (5-year cumulative incidence: 4.6% vs. 3.5%; p = 0.235). Subgroup analysis revealed no specific subgroup demonstrating improved DFS or OS after undergoing wedge resection or segmentectomy. Conclusion: DFS, OS, and lung cancer-specific mortality were comparable between wedge resection and segmentectomy of cN0 NSCLC-tumor size ≤ 2 cm and CTR > 0.25. Large-scale prospective clinical trials are warranted to compare the prognoses of wedge resection and segmentectomy for these tumors.

Indexed as

disease-free survivaloverall survivalprognosispropensity score matchingsegmentectomywedge resection

Identifiers

PMID37700837
PMCPMC10493869
OpenAlexW4386231486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.